$6.12
-0.09-1.45%
가까이에: Nov 19, 4:00 PM EST
$6.00
-0.12-1.96%
시간외: 7:42 PM EST
The average analyst price target for Eupraxia Pharmaceuticals is $16.71, 178.5% above the current price. Of 8 analysts, 8 rate it Buy. Targets range from $9 to $25. The latest change came on Nov 11, 2026, when HC Wainwright & Co. raised its price target on Eupraxia Pharmaceuticals from $11 to $16 and kept a Buy rating.
Price Target Range — 7 Quarters
Analyst Consensus — 8 Analysts
Rating Trend — Last 9 Months
